Smoking Cessation

More adults with exclusive daily e-cigarette use receiving 8-week varenicline quit than those receiving placebo, according to a research letter published in American Journal of Preventive Medicine.

A rheumatology clinic initiative to connect patients with smoking cessation resources was feasible, cost-effective and boosted referrals to the state quit line 20-fold, according to data published in Arthritis Care & Research.

An offer to speak with a smoking cessation practitioner during a lung cancer screening appointment was accepted by a majority of current smokers, according to results published in European Respiratory Journal.

Cytisinicline was associated with a greater rate of nicotine-containing e-cigarette cessation compared with placebo during 12 weeks of treatment and up to 4 weeks posttreatment, according to results from the phase 2 ORCA-VI trial.

BOSTON — Life’s Essential 8, a campaign led by the American Heart Association, is an assortment of interventions “we can all follow” and “associated with much better outcomes,” Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA, said.

BOSTON — Although recent evidence suggests that e-cigarettes may be an effective smoking cessation tool, further studies are needed to evaluate their efficacy and safety, according to an expert.

SAN DIEGO — The implementation of dietary modifications, supplementation and other lifestyle changes can significantly improve hidradenitis suppurativa, according to a speaker here.

Individuals using e-cigarettes for smoking cessation had a higher 6-month abstinence rate than nicotine replacement therapy users and a similar rate to varenicline users, according to results published in JAMA Internal Medicine.

Healio has compiled the most-read news in pulmonology posted in January.

Individuals using nicotine e-cigarettes have a higher likelihood of quitting smoking compared with nicotine replacement therapy users, according to data published in Cochrane Database of Systematic Reviews.